Editorial

The secrecy of drug regulatory information

M.J. Eadie
  • 1 August 2002
Feature

Database of Individual Patient Experiences (DIPEx)

Margaret Wohlers, Meredith Carter
  • 1 August 2002
Dental notes

Consumer Medicine Information: dental requirements

R.G. Woods, N. Savage, Australian Dental Association
  • 1 August 2002
Letters to the Editor

Your questions to the PBAC

  • 1 August 2002
Article

Managing constipation in children

95448fbeea204505
  • 1 August 2002
Letters to the Editor

Search engines

Leora Ross
  • 1 February 2002
Article

Warfarin, antiplatelet drugs and their interactions

Lye Lin Ho, Timothy Brighton
  • 1 August 2002
Article

Treatment of ocular toxoplasmosis

Paul Ng, Peter J. McCluskey
  • 1 August 2002
Letters to the Editor

Does pethidine still have a place in therapy?

P. Macintyre, F. Bochner, S. Wiltshire, Allan Molloy
  • 1 August 2002
Letters to the Editor

Support for Australian Prescriber

S. Rudd
  • 1 August 2002
Abnormal laboratory results

Skin prick testing and in vitro assays for allergic sensitivity

Richard M. O'Brien, Head
  • 1 August 2002
NEW DRUGS
Oxcarbazepine
  • 1 July 2002
Dorzolamide/timolol
  • 1 July 2002
Flucloxacillin sodium
  • 1 July 2002
Bisoprolol fumarate
  • 1 July 2002
Mesalasine
  • 1 July 2002
Sirolimus
  • 1 July 2002
Moroctocog alfa
  • 1 July 2002
Propofol
  • 1 July 2002
Lenograstin (rch)
  • 1 July 2002
Ertapenem
  • 1 July 2002
Levonorgestrel
  • 1 July 2002
Midazolam
  • 1 July 2002
Follitropin alfa
  • 1 July 2002
Cephalexin
  • 1 July 2002
Parecoxib
  • 1 July 2002
Riluzole
  • 1 July 2002
Aciclovir
  • 1 July 2002
Fondaparinux sodium
  • 1 July 2002

IF YOU PRESCRIBE SUBSCRIBE

If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe